Antithrombotic Therapy of Acute Stroke: Thrombolytic Agents

Gregory J del Zoppo

doi:10.1055/s-0038-1657523

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1997; 78(01): 183-190
DOI: 10.1055/s-0038-1657523

Antithrombotic therapy of acute stroke

Schattauer GmbH Stuttgart

Antithrombotic Therapy of Acute Stroke: Thrombolytic Agents

Gregory J del Zoppo

Department of Molecular and Experimental Medicine, Scripps Research Institute; Division of Hematology/Medical Oncology, Scripps Clinic and Research Foundation, La Jolla, CA, USA

› Author Affiliations

Abstract

PDF Download

PDF (1622 kb)

References

References
1 Sussman BJ, Fitch TSP. Thrombolysis with fibrinolysin in cerebral arterial occlusion. JAMA 1958; 167: 1705-1709
2 del ZoppoGJ, Zeumer H, Harker LA. Thrombolytic therapy in acute stroke:Possibilities and hazards. Stroke 1986; 17: 595-607
3 Fieschi C, Argentino C, Lenzi GL, Sacchetti ML, Toni D, Bozzao L. Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci 1989; 91: 311-321
4 del ZoppoGJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O, Greenlee Jr R, Brass L, Mohr JP, Feldmann E, Hacke W, Kase CS, Biller J, Gress D, otis SM. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992; 32: 78-86
5 Fieschi C, Bozzao L. Transient embolic occlusion of the middle cerebral and internal carotid arteries in cerebral apoplexy. J Neurol Neurosurg Psychiatry 1969; 32: 236-240
6 Solis oJ, Roberson GR, Taveras JM, Mohr J, Pessin MS. Cerebral angiography in acute cerebral infarction. Revist Interam Radiol 1977; 02: 19-25
7 Irino T, Taneda M, Minami T. Angiographic manifestations in post-recanalized cerebral infarction. Neurology 1977; 27: 471-475
8 Yamaguchi T, Minematsu K, Choki J, Ikeda M. Clinical and neuroradiological analysis of thrombotic and embolic cerebral infarction. Jpn Circ J 1984; 48: 50-58
9 Mori E, Yoneda Y, Tabuchi M, Yoshida T, Ohkawa S, Ohsumi Y, Kitano K, Tsutsumi A, Yamadori A. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992; 42: 976-982
10 Yamaguchi T. Intravenous tissue plasminogen activator in acute thromboembolic stroke:A placebo-controlled, double-blind trial. In: Thrombolytic Therapy in Acute Ischemic Stroke II. del ZoppoGJ, Mori E, Hacke W. eds Springer-Verlag; Heidelberg: 1993. pp 59-65
11 von KummerR, Hacke W. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery. Stroke 1992; 23: 646-652
12 Baron JC, von KummerR, del ZoppoGJ. Treatment of acute ischemic stroke. Challenging the concept of a rigid and universal time window (Editorial). Stroke 1995; 26: 2219-2221
13 Grau AJ, Buggle F, Heindl S, Steichen-Wiehn C, Banerjee T, Mariwald M, Rohlfc M, Suhr H, Fiehn W, Becher H, Hacke W. Recent infection as a risk factor for cerebrovascular ischemia. Stroke 1995; 26: 373-379
14 Mori E. Fibrinolytic recanalization therapy in acute cerebrovascular thromboembolism. In: Thrombolytic Therapy in Acute Ischemic Stroke. Hacke W, del ZoppoGJ, Hirschberg M. eds Springer-Verlag; Heidelberg: 1991. pp 137-46
15 del ZoppoGJ, Ferbert A, Otis S, Briickmann H, Hacke W, Zyroff J, Harker LA, Zeumer H. Local intra-arterial fibrinolytic therapy in acute carotid territory stroke:A pilot study. Stroke 1988; 19: 307-313
16 Mori E, Tabuchi M, Yoshida T, Yamadori A. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke 1988; 19: 802-812
17 Astrup J, Symon L, Branston NM, Lassen N. Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia. Stroke 1977; 08: 51-57
18 Astrup J, Siesjö BK, Symon L. Thresholds in cerebral ischemia—The ischemic penumbra. Stroke 1981; 12 (06) 723-725
19 Skyhoj-Olsen T, Larsen B, Herring M, Skawer EB, Lassen NA. Blood flow and vascular reactivity in collateral perfused brain tissue:Evidence of an ischemic penumbra. Stroke 1983; 14: 332-341
20 Aldrich MS, Sherman SA, Greenberg HS. Cerebrovascular complications of streptokinase infusion. JAMA 1985; 253: 1777-1779
21 Fletcher AP, Alkjaersig N, Lewis M, Tulevski V, Davies A, Brooks JE, Mardin WB, Landau WM, Raichle ME. A pilot study of urokinase therapy in cerebral infarction. Stroke 1976; 07: 135-142
22 Hommel M, Boissel JP, Cornu C, Boutitie F, Lees KR, Bessom G, Leys D, Amarenio P, Bogart M. for the MAST Group Termination of trial of streptokinase in severe acute ischemic stroke (Letter). Lancet 1995; 345: 578-579
23 The Multicenter Acute Stroke Trial-Europe Study Group. Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med 1996; 335: 145-150
24 Donnan GA, Davis SM, Chambers BR, Gates PC, Hankey GJ, McNeil JJ, Rosen D, Stewart-Wynne EC, Tuck RR. Trials of streptokinase in severe acute ischaemic stroke. Lancet 1995; 345: 578-579
25 Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von KummerR, Boysen G, Bluhmki E, Hoxter G, Mahagne M-H, Hennerici M. for the ECASS Study Group Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017-1025
26 The National Institutes of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-1587
27 Pessin MS, del ZoppoGJ, Estol CJ. Thrombolytic agents in the treatment of stroke. Clin Neuropharmacol 1990; 13: 271-289
28 Pessin MS, Teal PA, Caplan LR. Hemorrhagic infarction: Guilt by association. AJNR 1991; 12: 1123-1126
29 Okada Y, Yamaguchi T, Minematsu K, Miyashita T, Sawada T, Sadoshima S, Fujishima M, Omae T. Hemorrhagic transformation in cerebral embolism. Stroke 1989; 20: 598-603
30 Drake ME, Shin C. Conversion of ischemic to hemorrhagic infarction by anticoagulant administration. Report of two cases with evidence from serial computed tomographic brain scans. Arch Neurol 1983; 40: 44-46
31 Meyer JS, Gilroy J, Barnhart MI, Johnson JF. Therapeutic thrombolysis in cerebral thromboembolism. Neurology 1963; 13: 927-937
32 Babikian VL, Kase CS, Pessin MS, Norrving B, Gorelick PB. Intracerebral hemorrhage in stroke patients anticoagulated with heparin. Stroke 1989; 29: 1500-1503
33 Furlan AJ, Cavalier SJ, Hobbs RE, Weinstein MA, Modic MI. Hemorrhage and anticoagulation after nonseptic embolic brain infarction. Neurology 1982; 32: 280-282
34 Koller RL. Recurrent embolic cerebral infarction and anticoagulation. Neurology 1982; 32: 283-285
35 Mori E, Yoneda Y, Ohkawa S, Yoshida T, Ohsumi Y, Tabuchi M, Yamadori A, Kitano K, Tsutsumi A. Double-blind placebo-controlled trial of intravenous recombinant tissue plasminogen activator (rt-PA) in acute carotid stroke. Neurology 1991; 41 (Suppl. 01) 347
36 Ogata J, Yutani C, Imakita M, Ishibashi-Ueda H, Saku Y, Minematsu K, Sawada T, Yamaguchi T. Hemorrhagic infarct of the brain without a reopening of the occluded arteries in cardioembolic stroke. Stroke 1989; 20: 876-883
37 Fisher CM, Adams RD. Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction. J Neuropathol Exp Neurol 1951; 10: 92-94
38 Fisher CM, Adams RD. Observations on brain embolism with special reference to hemorrhage infarction. In: The Heart and Stroke. Exploring Mutual Cerebrovascular and Cardiovascular Issues. Furlan AJ. ed Springer-Verlag; New York: 1987. pp 17-36
39 Levy DE, Brott TG, Haley Jr EC, Marler JR, Sheppard GL, Barsan W, Broderick JP. Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke. Stroke 1994; 25: 291-297
40 Ueda T, Hatakeyama T, Kumon Y, Sakaki S, Uraoka T. Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT. Stroke 1994; 25: 298-303
41 Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke—Background and study protocol. Stroke 1985; 16: 885-890
42 Rankin J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J 1957; 02: 200-215
43 Loewen SC, Anderson BA. Reliability of the modified motor assessment scale and the Barthel index. Phys Ther 1988; 68: 1077-1081
44 Mahoney FJ, Barthel DW. Functional evaluation. The Barthel index. Md Med J 1965; 14: 61-65
45 Coté R, Hachinski VC, Shurtell BL, Norris JW, Wolfson C. The Canadian Neurological Scale: A preliminary study in acute stroke. Stroke 1986; 17: 731-737
46 Clarke RL, Cliffton EE. The treatment of cerebrovascular thrombosis and embolism with fibrinolytic agents. Am J Cardiol 1960; 30: 546-551
47 Herndon RM, Meyer JS, Johnson JF, Landers J. Treatment of cerebrovascular thrombosis with fibrinolysin. Preliminary report. Am J Cardiol 1960; 30: 540-545
48 Meyer JS, Gilroy J, Barnhart MI, Johnson JF. Anticoagulants plus streptokinase therapy in progressive stroke. JAMA 1964; 189: 373
49 Hanaway J, Torack R, Fletcher AP, Landau WM. Intracranial bleeding associated with urokinase therapy for acute ischemic hemispheral stroke. Stroke 1976; 7: 143-146
50 NIH Consensus Conference. Thrombolytic therapy in treatment. Br Med J 1980; 280: 1585-1587
51 Abe T, Kazawa M, Naito I, Kanaya H, Machino R, Igata A, Tazaki Y, Kameyama M, Goto F, Maezawa H, Watanabe H, Urushiyama K, Togi H, Sakuragawa N, Atarashi J, Kito S, Araki OnoderaH, Otomo E, Ogawa N. Clinical effect of urokinase (60,000 units/day) on cerebral infarction — Comparative study by means of multiple center double blind test. Blood Vessel 1981; 12: 342-358
52 Abe T, Kazama M, Naito I, Ueda M, Tanaka T, Higuchi H, Saso S, Kariyone S, Yoshimura M, Maekawa T, Morimatsu M, Moriyasu N, Takagi S, Maezawa H, Kase M, Kuwana N, Odakura T, Takasu K, Sugawara Y, Takahashi A, Okubo M, Ijichi H, Yamamoto S, Kikuchi H, Kito S, Tokito S, Iwasaki Y. Clinical evaluation for efficacy of tissue culture urokinase (TCUK) on cerebral thrombosis by means of multicenter double-blind study. Blood Vessel 1981; 12: 321-341
53 Atarashi J, Otomo E, Araki G, Itoh E, Togi H, Matsuda T. Clinical utility of urokinase in the treatment of acute stage of cerebral thrombosis: Multi-center double-blind study in comparison with placebo. Clin Eval 1985; 13: 659-709
54 Otomo E, Araki G, Itoh E, Tohgi H, Matuda T, Atarashi J. Clinical efficacy of urokinase in the treatment of cerebral thrombosis. Clin Eval 1985; 13: 711-751
55 Otomo E, Tohgi H, Hirai S, Terashi A, Takakura K, Araki G, Ito MatsudaT, Sawada T, Fujishine M, Ogawa Y. Clinical efficacy of AK-124 (tissue plasminogen activator) in the treatment of cerebral thrombosis:Study by means of multi-center double blind comparison with urokinase. Yakuri To Chiryo 1988; 16: 3775-3821
56 Abe T, Machii K, Kajiwara N, Kawai C, Kanmatsuse K, Kanbara NobuyoshiM, Yamaguchi T, Osada H, Kawada H, Matsuo O. Clinical usefulness of intravenous application of SM-9527 (duteplase; t-PA) in acute myocardial infarction: A multicentered, double-blind comparative study with intravenous administration of urokinase. Clin Eval 1989; 17: 485-515
57 Zeumer H, Freitag HJ, Grzyka U, Neunzig HP. Local intra-arterial fibrinolysis in acute vertebrobasilar occlusion. Technical developments and recent results. Neuroradiology 1989; 31: 336-340
58 Zeumer H. Survey of progress:Vascular recanalizing techniques in interventional neuroradiology. J Neurol 1985; 231: 287-294
59 Theron J, Courtheoux P, Casaseo A, Alachkar F, Notari F, Garen MaizaD, Maiza D. Local intra-arterial fibrinolysis in the carotid territory. AJNR 1989; 10: 753-765
60 Matsumoto K, Satoh K. Topical intraarterial urokinase infusion for acute stroke. In: Thrombolytic Therapy in Acute Ischemic Stroke. Hacke W, del ZoppoGJ, Hirschberg M. eds Springer-Verlag; Heidelberg: 1991. pp 207-212
61 Hacke W, Zeumer H, Ferbert A, Brückmann H, del ZoppoGJ. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988; 19: 1216-1222
62 Möbius E, Berg-Dammer E, Kühne D, Nahser HC. Local thrombolytic therapy in acute basilar artery occlusion: Experience with 18 patients. In: Thrombolytic Therapy in Acute Ischemic Stroke. Hacke W, del ZoppoGJ, Hirschberg M. eds Springer-Verlag; Heidelberg: 1991. pp 213-215
63 Zeumer H, Freitag H-J, Zarella F, Thie A, Arnig C. Local intra-arterial fibrinolytic therapy in patients with stroke: Urokinase vs recombinant tissue plasminogen activator (rt-PA). Neuroradiology 1993; 35: 159-162
64 Freitag H-J, Zeumer H, Knospe V. Acute central retinal artery occlusion and the role of thrombolysis. In: Thrombolytic Therapy in Acute Ischemic Stroke II. del ZoppoGJ, Mori E, Hacke W. eds Springer-Verlag; Heidelberg: 1993. pp 103-105
65 Ohtaki M, Shinya T, Yamamura A, Minamida Y. et al Local fibrinolytic therapy using superselective catheterization for patients with acute cerebral embolism within 10 hours. In: Microcirculatory Stasis in the Brain. Tomita M, Mchedlishvili A, Rosenblum W, Heiss W-D, Fukuuchi Y. eds. Elsevier Science; Amsterdam: 1993. pp 539-545
66 Higashida RT, Halbach VV, Barnwell SL, Dowd CF, Hieshima GB. Thrombolytic therapy in acute stroke. J Endovasc Surg 1994; 01: 04-15
67 Barnwell SL, Clark WM, Nguyen TT, O’Neill OR, Wynn ML, Coull BM. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. AJNR 1994; 15: 1817-1822
68 Jansen O, von KummerR, Forsting M, Hacke W, Sartor K. Thrombolytic therapy in acute occlusion of the intracranial internal carotid artery bifurcation. AJNR 1995; 16: 1977-1986
69 von KummerR, Forsting M, Sartor K, Hacke W. Intravenous recombinant tissue plasminogen activator in acute stroke. In: Thrombolytic Therapy in Acute Ischemic Stroke. Hacke W, del ZoppoGJ, Hirschberg M. eds Springer; Heidelberg: 1991. pp 161-167
70 Yamaguchi T. Intravenous rt-PA in acute embolic stroke. In: Thrombolytic Therapy in Acute Ischemic Stroke. Hacke W, del ZoppoGJ, Hirschberg M. eds Springer-Verlag; Heidelberg: 1991. pp 168-174
71 Yamaguchi T, Kikuchi H, Hayakawa T. for the Japanese Thrombolysis Study Group Clinical efficacy and safety of intravenous tissue plasminogen activator in acute embolic stroke: A randomized, double-blind, dose-comparison study of duteplase. In: Thrombolysis in Acute Ischemic Stroke III. Yamaguchi T, Mori E, Minematsu K, del ZoppoGJ. eds Springer-Verlag; Tokyo: 1995. pp 223-229
72 Yamaguchi T, Hayakawa T, Kiuchi H. Intravenous tissue plasminiogen activator ameliorates the outcome of hyperacute embolic stroke. Cerebrovasc Dis 1993; 03: 269-272
73 Multicentre Acute Stroke Trial-Italy (MAST-I) Group. Randomised controlled trial of streptokinase, aspirin, and combination.of both in treatment of acute ischaemic stroke. Lancet 1995; 346: 1509-1514
74 Tognoni G, Roncaglioni MC. Dissent:An alternative interpretation of MAST-I. Lancet 1995; 346: 1515
75 Gruppo Italiano Per Lo Studio Della Streptochinasi Nell’Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 01: 397-401
76 Gruppo Italiano Per Lo Studio Della Streptochinasi Nell’Infarto Miocardico (GISSI). GISSI-2:A factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet 1990; 336: 65-71
77 Haley Jr EC, Levy DE, Brott TG, Sheppard GL, Wong MCW, Kongable GL, Tomer JC, Marler JR. Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke 1992; 23: 641-645
78 Haley Jr EC, Brott TG, Sheppard GL, Barsan W, Broderick J, Marler JR, Kongable GL, Spilker J, Massey S, Hansen CA, Tomer JC. Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. Stroke 1993; 24: 1000-1004
79 Brott TG, Haley Jr EC, Levy DE, Barsan W, Broderick J, Sheppard GL, Spilker J, Kongable GL, Massey S, Reed R, Marler JR. Urgent therapy for stroke. Part I. Pilot study of tissue plaminogen activator administered within 90 minutes. Stroke 1992; 23: 632-640
80 Nenci GG, Gresele P, Taramelli M, Agnelli G, Signorini E. Thrombolytic therapy for thromboembolism of vertebrobasilar artery. Angiology 1983; 34: 561-571
81 Kwaan HC. Thromboembolic disorders of the eye. In: Thrombolytic Therapy. Comerota AC. ed Grune and Stratton; Orlando: 1988. pp 153-163
82 Schmidt D, Schumacher M, Wakhloo AK. Microcatheter urokinase infusion in central retinal artery occlusion. Am J Ophthalmol 1992; 113: 429-434
83 del ZoppoGJ, Higashida RT, Furlan AJ, Pessin MS, Gent M, Driscoll RM. and the PROACT Investigators The Prolyse in Acute Cerebral Thromboembolism Trial (PROACT): Results of 6 mg dose tier. Stroke 1996; 27: 164 (Abstract)